AbbVie Inc. (ABBV) Social Stream
ABBVIE INC (ABBV) Price Targets From Analysts
Use the tables below to see what analysts covering ABBVIE INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 13 | $140 | $118 | $128 | $133.44 | -4.08% |
| 2021-11-23 | 12 | $172 | $118 | $133.083 | $133.44 | -0.27% |
| 2022-01-03 | 13 | $172 | $118 | $135.538 | $133.44 | 1.57% |
| 2022-01-05 | 13 | $172 | $118 | $140.923 | $133.44 | 5.61% |
| 2022-01-14 | 13 | $172 | $118 | $143.416 | $133.44 | 7.48% |
| 2022-01-19 | 13 | $172 | $118 | $147.166 | $133.44 | 10.29% |
| 2022-02-01 | 13 | $172 | $133 | $149.916 | $133.44 | 12.35% |
| 2022-02-03 | 13 | $180 | $133 | $151.416 | $133.44 | 13.47% |
| 2022-02-14 | 13 | $180 | $133 | $153.5 | $133.44 | 15.03% |
| 2022-02-17 | 14 | $180 | $133 | $154.083 | $133.44 | 15.47% |
| 2022-03-08 | 14 | $180 | $133 | $153.538 | $133.44 | 15.06% |
| 2022-03-16 | 14 | $180 | $133 | $154.076 | $133.44 | 15.46% |
| 2022-04-06 | 13 | $192 | $133 | $159.833 | $133.44 | 19.78% |
| 2022-04-13 | 12 | $192 | $147 | $163.25 | $133.44 | 22.34% |
| 2022-04-18 | 13 | $192 | $147 | $165.75 | $133.44 | 24.21% |
| 2022-04-22 | 13 | $192 | $147 | $166.083 | $133.44 | 24.46% |
| 2022-04-29 | 13 | $192 | $147 | $167.833 | $133.44 | 25.77% |
| 2022-05-02 | 13 | $200 | $147 | $170.75 | $133.44 | 27.96% |
| 2022-05-11 | 13 | $200 | $147 | $168.846 | $133.44 | 26.53% |
| 2022-05-20 | 14 | $200 | $140 | $166.785 | $133.44 | 24.99% |
| 2022-06-09 | 15 | $200 | $140 | $165 | $133.44 | 23.65% |
| 2022-07-22 | 15 | $200 | $140 | $165.2 | $133.44 | 23.8% |
| 2022-07-29 | 14 | $200 | $140 | $165.2 | $133.44 | 23.8% |
| 2022-08-01 | 16 | $200 | $140 | $165 | $133.44 | 23.65% |
| 2022-08-24 | 15 | $200 | $140 | $163.562 | $133.44 | 22.57% |
| 2022-09-21 | 16 | $200 | $140 | $163.562 | $133.44 | 22.57% |
| 2022-10-03 | 16 | $200 | $135 | $163.25 | $133.44 | 22.34% |
| 2022-10-12 | 16 | $200 | $135 | $163.062 | $133.44 | 22.2% |
| 2022-10-28 | 16 | $200 | $135 | $163.312 | $133.44 | 22.39% |
| 2022-10-31 | 16 | $200 | $135 | $162.25 | $133.44 | 21.59% |
| 2022-11-01 | 16 | $200 | $135 | $161.937 | $133.44 | 21.36% |
| 2022-12-04 | 16 | $200 | $135 | $161.266 | $133.44 | 20.85% |
| 2022-12-05 | 16 | $200 | $135 | $161.4 | $133.44 | 20.95% |
| 2022-12-06 | 16 | $200 | $135 | $161.666 | $133.44 | 21.15% |
| 2022-12-13 | 15 | $200 | $135 | $161.866 | $133.44 | 21.3% |
| 2023-01-04 | 15 | $200 | $135 | $162.533 | $133.44 | 21.8% |
| 2023-01-11 | 15 | $200 | $135 | $164.571 | $133.44 | 23.33% |
| 2023-01-27 | 15 | $200 | $135 | $164.714 | $133.44 | 23.44% |
| 2023-02-08 | 15 | $200 | $135 | $164.357 | $133.44 | 23.17% |
| 2023-02-09 | 15 | $200 | $135 | $164.571 | $133.44 | 23.33% |
| 2023-02-13 | 15 | $200 | $140 | $166 | $133.44 | 24.4% |
| 2023-03-31 | 16 | $200 | $140 | $165.733 | $133.44 | 24.2% |
| 2023-04-10 | 16 | $200 | $140 | $165.933 | $133.44 | 24.35% |
| 2023-04-26 | 15 | $200 | $146 | $168.142 | $133.44 | 26.01% |
| 2023-04-28 | 16 | $195 | $146 | $167.714 | $133.44 | 25.68% |
| 2023-05-05 | 16 | $195 | $146 | $167.785 | $133.44 | 25.74% |
| 2023-05-22 | 16 | $195 | $146 | $169.153 | $133.44 | 26.76% |
The Trend in the Analyst Price Target
Over the past 43 weeks, ABBV's average price target has gone up $3.95.
Over the past 50 weeks, ABBV's average upside potential has been 9.76%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-01 | 15 | 200 | 140 | 163.625 | 140.22 | 16.69% |
| 2022-09-10 | 16 | 200 | 140 | 163.562 | 141.42 | 15.66% |
| 2022-09-17 | 16 | 200 | 140 | 163.562 | 144.06 | 13.54% |
| 2022-10-13 | 16 | 200 | 135 | 163.312 | 142.92 | 14.27% |
| 2022-10-31 | 16 | 200 | 135 | 162.250 | 146.40 | 10.83% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.03 | 7 | 1 | 8 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 26 weeks, ABBV's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, ABBVIE INC's average analyst price target is greater than 5019.05% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ABBVIE INC's number of analysts covering the stock is greater than 5171.38% of them.
- In terms of how ABBVIE INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1032.08% of that group.
- In the context of Pharmaceutical Products stocks, ABBVIE INC's variance in analysts' estimates is lower than -1101% of them.
In the Pharmaceutical Products industry, MRK, JNJ, and PFE are the three stocks most similar to ABBVIE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ABBV a Buy, Hold or Sell? See the POWR Ratings now!